Colin F. Spraggs
Publications by Year
Research Areas
Renal cell carcinoma treatment, Helicobacter pylori-related gastroenterology studies, Chronic Lymphocytic Leukemia Research, Pancreatic and Hepatic Oncology Research, Lung Cancer Treatments and Mutations
Most-Cited Works
- → HLA-DQA1 * 02:01 Is a Major Risk Factor for Lapatinib-Induced Hepatotoxicity in Women With Advanced Breast Cancer(2011)276 cited
- → Antiemetic activity of the NK1 receptor antagonist GR205171 in the treatment of established postoperative nausea and vomiting after major gynaecological surgery(1999)167 cited
- → Pazopanib Efficacy in Renal Cell Carcinoma: Evidence for Predictive Genetic Markers in Angiogenesis-Related and Exposure-Related Genes(2011)148 cited
- → Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism(2010)119 cited
- → HLA-B *57:01 Confers Susceptibility to Pazopanib-Associated Liver Injury in Patients with Cancer(2015)95 cited
- → Potential Impact of Adding Genetic Markers to Clinical Parameters in Predicting Prostate Biopsy Outcomes in Men Following an Initial Negative Biopsy: Findings from the REDUCE Trial(2012)90 cited
- → Prospective Validation of HLA-DRB1*07:01 Allele Carriage As a Predictive Risk Factor for Lapatinib-Induced Liver Injury(2014)76 cited
- → Comprehensive genome-wide evaluation of lapatinib-induced liver injury yields a single genetic signal centered on known risk allele HLA-DRB1*07:01(2015)62 cited
- → Lapatinib-Induced Liver Injury Characterized by Class II HLA and Gilbert's Syndrome Genotypes(2012)50 cited
- → Association of the hemochromatosis gene with pazopanib-induced transaminase elevation in renal cell carcinoma(2010)50 cited